Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas

Abstract

The chromosomal translocation t(X;18)(p11.2;q11.2) is tightly linked to the tumorigenesis of synovial sarcoma. Through this translation the SYT gene on chromosome 18 is fused with a testis/cancer antigen gene on the X chromosome, generating either a SYT-SSX1, SYT-SSX2, or less often a SYT-SSX4 fusion gene. It has been anticipated that the individual synovial sarcoma carries only one of these variants, however, in this study we demonstrated that SYT-SSX1 and SYT-SSX2 co-exist in a significant proportion of the cases. From 121 SYT-SSX positive primary tumors, co-expression of SYT-SSX1 and SYT-SSX2 was seen in 12 cases (10%), which were characterized in further detail both at the RNA, DNA and chromosomal level. In all 12 cases the SYT-SSX1 and SYT-SSX2 fusions resulted in identical SYT-SSX fusion transcripts. However, at the genomic level the translocations were different, and most likely occurred between variable intronic sites in the target genes. By interphase FISH analyses of 10 cases SYT-SSX2 translocations were found to be the most abundant in all but one of the cases, in which SYT-SSX1 was predominating. The findings reveal a new heterogenous feature of synovial sarcoma, accounting for approximately 10% of all cases, which may shed light on the molecular genetic mechanisms behind translocations in general, and on the etiology of synovial sarcoma in particular.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Åman P . 1999 Cancer Biol. 9: 303–318

  • Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G . 1997 Hum. Mol. Genet. 6: 1559–1564

  • Brodin B, Haslam K, Yang K, Bartolazzi A, Xie Y, Starborg M, Lundeberg J, Larsson O . 2001 Gene 268: 173–182

  • Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA, Cooper CS . 1994 Nat. Genet. 7: 502–508

  • Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS . 1995 EMBO J. 14: 2333–2340

  • de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A . 1995 Hum. Mol. Genet. 4: 1097–1099

  • Eid JE, Kung AL, Scully R, Livingston DM . 2000 Cell 102: 839–848

  • Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M . 1995 Am. J. Pathol. 147: 1592–1599

  • Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, Chen YT . 1997 Int. J. Cancer 72: 965–971

  • Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M . 1998 N. Engl. J. Med. 338: 153–160

  • Kovalchuk AL, Müller JR, Janz S . 1997 Oncogene 15: 2369–2377

  • Ladanyi M, Bridge JA . 2000 Hum. Pathol. 31: 532–538

  • Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC . 1998 Oncogene 17: 2013–2018

  • Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H, Minami A, Hiraga H, Nishihara H, Sawa H, Nagashima K . 2001 Proc. Natl. Acad. Sci. USA 98: 3843–3848

  • Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlen M, Larsson O . 1999 Cancer Res. 59: 3180–3184

  • O'Dwyer ME, Druker BJ . 2000 Curr. Opin. Oncol. 12: 594–597

  • Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Åkerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Debiec-Rychter M, Szadowska A, Brosjö O, Larsson O, Rydholm A, Mandahl N . 2001 Genes Chromosomes Cancer 31: 362–372

  • dos Santos NR, de Bruijn DR, Guerts van Kessel A . 2001 Genes Chromosomes Cancer 30: 1–14

  • Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlen M, Larsson O . 1999 J. Natl. Cancer Inst. 91: 974–975

  • Sreekantaiah C . 1998 Cytogenet. Cell. Genet. 82: 13–29

  • Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM, Zimmerman R, Parry DM, Cowan JM, Sandberg AA . 1987 Proc. Natl. Acad. Sci. USA 84: 1981–1985

Download references

Acknowledgements

The authors would like to thank Dr Yaping Jin for help with the statistical analyses and Dr Armando Bartolazzi for valuable comments on the manuscript. This study was supported by The Swedish Cancer Foundation, the Milton Foundation, the Cornell Foundation, the Cancer Society in Stockholm, the Swedish Children Cancer Society, the Stockholm County Council, and the Torsten and Ragnar Söderberg Foundations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olle Larsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, K., Lui, WO., Xie, Y. et al. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 21, 4181–4190 (2002). https://doi.org/10.1038/sj.onc.1205569

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205569

Keywords

This article is cited by

Search

Quick links